Murray Valley encephalitis virus infection is the clinical and surveillance entity associated with infection by Murray Valley encephalitis virus (MVEV), a mosquito-borne flavivirus [1]. The disease is treated in the sources as an Australian surveillance concept and as a topic of scholarly literature on neuroviral infection [2][3][4][5]. The source record does not provide additional etiologic detail beyond its viral and flaviviral characterization [1].
Disease Profile
Murray Valley encephalitis virus infection
墨累谷脑炎病毒感染
Murray Valley encephalitis virus infection is a mosquito-borne flaviviral infection recognized in Australian public-health surveillance, with documented human outbreaks in the Murray Valley region of south-eastern Australia [1]. Available source material describes it as an infrequent but potentially substantial outbreak-associated infection, and notes that significant mortality has occurred in affected human outbreaks [1]. In Victoria during the 2022-2023 mosquito season, an integrated response combined climate-informed risk assessment, mosquito surveillance, human case investigation, and equine surveillance [1].
The available evidence supports a severe neuroinvasive phenotype, as the virus is linked to encephalitic illness in human and equine surveillance contexts [1]. The outbreak report does not provide a detailed clinical syndrome, symptom sequence, or complication profile beyond noting significant mortality in human outbreaks [1]. Surveillance in Victoria included testing of serum and cerebrospinal fluid to evaluate flaviviruses, indicating that clinically relevant cases were investigated with serological and molecular algorithms [1]. Source-backed detail on incubation period, milder presentations, neurologic sequelae, or recovery course is not yet available [1].
Murray Valley encephalitis virus infection has been reported as causing infrequent yet substantial human outbreaks in the Murray Valley region of south-eastern Australia [1]. The 2022-2023 Victoria response documented active seasonal surveillance, with 3,186 mosquito trapping events between 1 July 2022 and 20 June 2023 and MVEV detected in mosquitoes on 48 occasions [1]. During the same period, human surveillance identified 6 confirmed cases and 2 flavivirus-unspecified cases, while equine surveillance tested 88 horses with clinical signs consistent with flavivirus infection and found one probable case and no confirmed cases of MVE [1]. The source material does not establish the full endemic range, reservoir ecology, or baseline annual burden beyond these outbreak-related findings [1].
The source material identifies mosquito-borne transmission as the key exposure pathway for Murray Valley encephalitis virus infection [1]. No additional route, vector species, or person-to-person transmission information is provided in the supplied snippets [1]. The available evidence is therefore limited to vector-associated exposure and mosquito surveillance as the operational basis for detection [1].
Source-backed risk-group detail is not yet available beyond exposure through mosquito-borne transmission and the use of equine surveillance as a sentinel component of the response [1]. The supplied material does not specify age, occupation, travel history, comorbidity, or other host factors associated with increased risk [1].
Prevention in the cited outbreak response relied on climate-informed pre-season risk assessment, vector surveillance with mosquito trapping and laboratory testing, integrated mosquito management, and active health promotion [1]. Human and equine surveillance were used to trigger response actions and broaden situational awareness during the mosquito season [1]. Source-backed detail on specific personal protective measures, environmental control thresholds, or vaccine use is not yet available [1].
In surveillance practice, Murray Valley encephalitis virus infection should be interpreted as an arboviral risk that may emerge through mosquito detections before or alongside human disease [1]. The Victoria response shows the value of integrating climate signals, mosquito testing, human diagnostic testing, and equine case investigation to detect transmission activity [1]. The source set supports reading this event as an outbreak-prone infection with potentially severe outcomes rather than a routine background diagnosis [1].
- 1 Braddick M et al. An integrated public health response to an outbreak of Murray Valley encephalitis virus infection during the 2022-2023 mosquito season in Victoria. Front Public Health. 2023. PMID: 37860808. doi: 10.3389/fpubh.2023.1256149. PubMed: https://pubmed.ncbi.nlm.nih.gov/37860808/
- 2 Murray Valley Encephalitis Virus. Neuroviral Infections. 2020. doi: 10.1201/b15082-13. DOI: https://doi.org/10.1201/b15082-13
- 3 Murray Valley encephalitis virus. CABI Compendium. 2019. doi: 10.1079/cabicompendium.96305. DOI: https://doi.org/10.1079/cabicompendium.96305
- 4 Murray Valley Encephalitis Virus. Encyclopedia of Medical Genomics and Proteomics. 2004. doi: 10.1081/e-emgp-120027609. DOI: https://doi.org/10.1081/e-emgp-120027609
- 5 Murray Valley Encephalitis Virus. Encyclopedia of Medical Genomics and Proteomics. 2004. doi: 10.3109/9780203997352.172. DOI: https://doi.org/10.3109/9780203997352.172
- 6 Wikidata contributors. Murray Valley encephalitis virus infection in mosquitoes and domestic fowls in Queensland, 1974 [Internet]. Wikidata. cited 20 May 2026. Available from: https://www.wikidata.org/wiki/Q39135305
Figure 1 | Full historical trajectories across all reporting countries.
Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.
Dataset Archive
Supplementary Data | Multi-country disease dataset
Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.
Source Register
Official sources and update cadences used to construct the downloadable dataset.
AU
Australia NINDSSmonthlymicrosoft_bi
Australia
Australian national notifiable diseases surveillance dashboard.
Official sourceSuggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.